NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].
Show details| Medication: | Bosentan (250 mg daily) |
| Pattern: | Mixed (R=2.5) |
| Severity: | 4+ (jaundice, hospitalization and prolongation of prothrombin time) |
| Latency: | 18 months |
| Recovery: | 6 weeks |
| Other medications: | Unspecified diuretics |
- Predictive model of bosentan-induced liver toxicity in Japanese patients with pulmonary arterial hypertension.[Can J Physiol Pharmacol. 2020]Predictive model of bosentan-induced liver toxicity in Japanese patients with pulmonary arterial hypertension.Yorifuji K, Uemura Y, Horibata S, Tsuji G, Suzuki Y, Nakayama K, Hatae T, Kumagai S, Emoto N. Can J Physiol Pharmacol. 2020 Sep; 98(9):625-628. Epub 2020 May 20.
- Review Endothelin receptor antagonist therapy in congenital heart disease with shunt-associated pulmonary arterial hypertension: a qualitative systematic review.[Can J Cardiol. 2009]Review Endothelin receptor antagonist therapy in congenital heart disease with shunt-associated pulmonary arterial hypertension: a qualitative systematic review.Fine N, Dias B, Shoemaker G, Mehta S. Can J Cardiol. 2009 Mar; 25(3):e63-8.
- VIP and endothelin receptor antagonist: an effective combination against experimental pulmonary arterial hypertension.[Respir Res. 2011]VIP and endothelin receptor antagonist: an effective combination against experimental pulmonary arterial hypertension.Hamidi SA, Lin RZ, Szema AM, Lyubsky S, Jiang YP, Said SI. Respir Res. 2011 Oct 26; 12(1):141. Epub 2011 Oct 26.
- Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cells.[PLoS One. 2012]Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cells.Gatfield J, Mueller Grandjean C, Sasse T, Clozel M, Nayler O. PLoS One. 2012; 7(10):e47662. Epub 2012 Oct 15.
- Review Endothelin Receptor Antagonists.[LiverTox: Clinical and Researc...]Review Endothelin Receptor Antagonists.. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012
- [Table, Key Points]. - LiverTox[Table, Key Points]. - LiverTox
Your browsing activity is empty.
Activity recording is turned off.
See more...